Cargando…

Targeted radioimmunotherapy with the iodine-131-labeled caerin 1.1 peptide for human anaplastic thyroid cancer in nude mice

OBJECTIVE: The combination of two or more drugs with different mechanisms is a promising strategy for cancer treatment, and radioimmunotherapy (RIT) is a trending antitumor strategy. Radiotherapy (RT) can promote and activate antitumor immune effects, and immunotherapy can strengthen the effects of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Ruoting, Ma, Bowei, Liu, Na, Zhang, Lu, He, Tiantian, Liu, Xiongying, Chen, Tongsheng, Liu, Wenjuan, Liang, Yongnan, Wang, Tianfang, Ni, Guoying, Liu, Xiaosong, Yang, Ning, Zhang, Jinhe, Yuan, Jianwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197720/ https://www.ncbi.nlm.nih.gov/pubmed/33948902 http://dx.doi.org/10.1007/s12149-021-01618-3

Ejemplares similares

(131)I-Caerin 1.1 and (131)I-Caerin 1.9 for the treatment of non-small-cell lung cancer
por: Liu, Na, et al.
Publicado: (2022)

Comparative Proteomic Study of the Antiproliferative Activity of Frog Host-Defence Peptide Caerin 1.9 and Its Additive Effect with Caerin 1.1 on TC-1 Cells Transformed with HPV16 E6 and E7
por: Ni, Guoying, et al.
Publicado: (2018)

Preclinical Pharmacokinetics, Biodistribution, and Acute Toxicity Evaluation of Caerin 1.9 Peptide in Sprague Dawley Rats
por: Yang, Xiaodan, et al.
Publicado: (2022)

Radioimmunotherapy with tositumomab and iodine-131 tositumomab for non-Hodgkin’s lymphoma
por: Andemariam, Biree, et al.
Publicado: (2007)

Caerin 1.1/1.9 Enhances Antitumour Immunity by Activating the IFN-α Response Signalling Pathway of Tumour Macrophages
por: Yang, Xiaodan, et al.
Publicado: (2022)

Caerin 1 Peptides, the Potential Jack-of-All-Trades for the Multiple Antibiotic-Resistant Bacterial Infection Treatment and Cancer Immunotherapy
por: Xiao, Liyin, et al.
Publicado: (2022)

Host-Defense Peptides Caerin 1.1 and 1.9 Stimulate TNF-Alpha-Dependent Apoptotic Signals in Human Cervical Cancer HeLa Cells
por: Ni, Guoying, et al.
Publicado: (2020)

Caerin 1.1 and 1.9 Peptides from Australian Tree Frog Inhibit Antibiotic-Resistant Bacteria Growth in a Murine Skin Infection Model
por: Chen, Shu, et al.
Publicado: (2021)

Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis
por: Lin, Ruoting, et al.
Publicado: (2021)

Radioimmunotherapy for Pancreatic Carcinoma Using (131)I‐Labeled Monoclonal Antibody Nd2 in Xenografted Nude Mice
por: Inui, Akimasa, et al.
Publicado: (1996)

Update on the rational use of tositumomab and iodine-131 tositumomab radioimmunotherapy for the treatment of non-Hodgkin’s lymphoma
por: Burdick, Michael J, et al.
Publicado: (2009)

Topical Application of Temperature-Sensitive Gel Containing Caerin 1.1 and 1.9 Peptides on TC-1 Tumour-Bearing Mice Induced High-Level Immune Response in the Tumour Microenvironment
por: Ni, Guoying, et al.
Publicado: (2021)

Intratumoral injection of caerin 1.1 and 1.9 peptides increases the efficacy of vaccinated TC‐1 tumor‐bearing mice with PD‐1 blockade by modulating macrophage heterogeneity and the activation of CD8(+) T cells in the tumor microenvironment
por: Ni, Guoying, et al.
Publicado: (2021)

Tissue Factor‐Targeted ImmunoPET Imaging and Radioimmunotherapy of Anaplastic Thyroid Cancer
por: Wei, Weijun, et al.
Publicado: (2020)

Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy
por: Kesavan, Murali, et al.
Publicado: (2017)

Radioimmunotherapy of human hepatocellular carcinoma xenografts with 131I-labelled antiferritin antibody.
por: Saiful Alam, A. F.
Publicado: (1991)

Radioimmunotherapy study of (131)I-labeled Atezolizumab in preclinical models of colorectal cancer
por: Zhang, Linhan, et al.
Publicado: (2022)

Radioimmunotherapy for CD133(+) colonic cancer stem cells inhibits tumor development in nude mice
por: Weng, Dinghu, et al.
Publicado: (2017)

Iodine-131 and Thyroid Function
por: Sun, Wenjie
Publicado: (2014)

Radioimmunotherapy of transplanted small cell lung cancer with 131I-labelled monoclonal antibody.
por: Yoneda, S., et al.
Publicado: (1988)

Enhanced tumor inhibiting effect of 131I-BDI-1-based radioimmunotherapy and cytosine deaminase gene therapy modulated by a radio-sensitive promoter in nude mice bearing bladder cancer
por: Hao, Pan, et al.
Publicado: (2022)

Intraperitoneal Alpha-Radioimmunotherapy of Advanced Ovarian Cancer in Nude Mice Using Different High Specific Activities
por: Elgqvist, Jorgen, et al.
Publicado: (2010)

Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies.
por: Lane, D. M., et al.
Publicado: (1994)

Standard Operating Procedure for In-house Preparation of (131)I-rituximab for Radioimmunotherapy of Non-Hodgkin's Lymphoma
por: Pickford, Matthew D., et al.
Publicado: (2012)

Fractionated (131)I anti-CEA radioimmunotherapy: effects on xenograft tumour growth and haematological toxicity in mice
por: Violet, J A, et al.
Publicado: (2008)

Standard Operating Procedure for Prospective Individualised Dosimetry for ([131])I-rituximab Radioimmunotherapy of Non-Hodgkin's Lymphoma
por: Calais, Phillipe J., et al.
Publicado: (2012)

Caerin 1 Antimicrobial Peptides that Inhibit HIV and Neisseria May Spare Protective Lactobacilli
por: Rollins-Smith, Louise A., et al.
Publicado: (2020)

Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM).
por: Antoniw, P., et al.
Publicado: (1996)

Low dosage of 131iodine effects on chromosomes.
por: Rodrigues, Claudia Lopes, et al.
Publicado: (2003)

Iodine-131: Lack of efficacy: case report
Publicado: (2022)

Importance of human papillomavirus infection in squamous cell carcinomas of the tongue in Guangdong Province, China
por: Huang, Kunsong, et al.
Publicado: (2020)

Rhenium‐186‐mercaptoacetyltriglycine‐labeled Monoclonal Antibody for Radioimmunotherapy: In vitro Assessment, in vivo Kinetics and Dosimetry in Tumor‐bearing Nude Mice
por: Kinuya, Seigo, et al.
Publicado: (1998)

Effectiveness and Safety of Levothyroxine Tablets Combined with Iodine-131 in the Treatment of Thyroid Cancer
por: Bai, Yang, et al.
Publicado: (2022)

Synthesized natural peptides from amphibian skin secretions increase the efficacy of a therapeutic vaccine by recruiting more T cells to the tumour site
por: Pan, Xuan, et al.
Publicado: (2019)

Interventional therapy for human breast cancer in nude mice with (131)I gelatin microspheres ((131)I-GMSs) following intratumoral injection
por: Li, Chuan-Chao, et al.
Publicado: (2014)

Genotoxicity induced by iodine-131 in human cultured lymphocytes
por: Hosseinimehr, Seyed Jalal, et al.
Publicado: (2013)

Drug-induced liver injury caused by iodine-131
por: Kim, Chei Won, et al.
Publicado: (2016)

HSA-MnO(2)-(131)I Combined Imaging and Treatment of Anaplastic Thyroid Carcinoma
por: Yan, Ziyu, et al.
Publicado: (2022)

Radioimmunotherapy of pancreatic cancer xenografts in nude mice using (90)Y-labeled anti-α(6)β(4) integrin antibody
por: Aung, Winn, et al.
Publicado: (2016)

Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target
por: Sabanathan, Dhanusha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_soepdnie0v6ls0q6nkrur4ifr2